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a  b  s  t  r  a  c  t
Cushing’s  syndrome  occurred  in  1–5% of  cases  of  bronchial  carcinoids.  In this  paper  we  describe  a case
of typical  bronchial  carcinoid  in a nonsmoker  young  male  with  clinical  manifestations  mimicking  aeywords:
ushing’s syndrome
ronchial carcinoid
ronchoscopy
Cushing’s  syndrome.  The  patient  performed  chest  radiograph  and  computed  tomography.  Fiberoptic
bronchoscopy  revealed  the  presence  of an  endobronchial  mass  occluding  the  bronchus  intermedius.  A
rigid bronchoscopy  was  necessary  for the  conclusive  diagnosis  and  for partial  resection  of the  intralumi-
nal  tumor.  Despite  of the  presence  of  Cushingoid  features,  the  normal  blood  levels  of ACTH and  cortisol
excluded  the  coexistence  of  a Cushing’s  syndrome.
©  2016  The  Authors.  Published  by Elsevier  Ltd.  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
Bronchial carcinoids represent a small portion of all pulmonary
umors and about 1–5% of them are associated with ectopic ACTH
ecretion, which represents 1–10% of Cushing’s syndrome cases
1–3]. Cushing’s syndrome (CS) is the result of chronic exposure
o increased concentration of cortisol hormone exogenous or endo-
enus, and it is generally associated with central obesity, metabolic
yndrome, hypertension. Neuropsycological disturbances are also
requently observed, including depression, emotional irritability,
leep disturbance and cognitive deﬁcits that can be the ﬁrst man-
festation perceived by family members of patients affected by
S. Treatment is based on decreasing of cortisol levels in blood,
hrough medical or surgical approaches. Surgery is considered the
ain treatment for ectopic ACTH-secreting tumors. We  describe aase of typical bronchial carcinoid associated with a Cushing’s like
yndrome.
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2. Case report
A 26 year-old severe obese male with an history of anxiety over
the last 5 years was admitted to our department of Respiratory
Medicine referring poorly cough, fever (39 ◦C), sputum and short-
ness of breath. He was  a nonsmoker and his weight, height and body
mass index were 163 kg, 1.90 m and 45.15 kg × m2, respectively.
A physical exam revealed round facies, extensive purple striae
on his abdomen and marked central obesity, mimicking Cushin-
goid features. Auscultation of the chest revealed hypophonesis and
reduction of breath sound of the basal right hemithorax. Pulse
was regular and blood pressure normal; the haemoglobin oxy-
gen saturation was  91% in room air. Laboratory data showed an
increase of neutrophilic count and hypertriglyceridemia. A chest
radiograph showed a lift of right hemidiaphragm with ipsilateral
scanty pleural effusion (Fig. 1). The clinical and radiological data
suggested the diagnosis of pneumonia and the patient was treated
with ciproﬂoxacin 400 mg  iv bid and systemic steroids for 10 days.
The treatment determined a substantial improvement of clinical
condition, but did not modify signiﬁcantly chest imagines. Sub-
sequently the patient performed a computed tomography that
revealed the presence of a solid mass in the bronchus intermedius
associated with a complete atelectasis of middle and lower right
lobe (Fig. 2a,b). Fibreoptic bronchoscopy revealed a pale tissue
with irregular margins measuring approximately 1 cm in diame-
ter and obliterating completely the bronchus intermedius (Fig. 3).
The endobronchial biopsies showed ﬁbrinoid material and micro-
calciﬁcations in the contest of a nonspeciﬁc granulation tissue but
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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(Fig. 1. Chest radiograph showing a lift of right h
ere not conclusive for a diagnosis. The patient underwent a rigid
ronchoscopy for diagnostic purpose and for partial resection of
he intraluminal mass.
Histophatological examination of endobronchial removed sam-
les showed a typical carcinoid tumor with a trabecular pattern and
ithout areas of necrosis, <2 mitoses per 2 mm2 detected by ki67
mmunostaining, high CD56 and high chromogranin expression
ndicating neuroendocrine differentiation. On the basis of diagnosis
f neuroendocrine tumor and Cushingoids features a blood test was
arried out which demonstrated normal levels of ACTH and corti-
ol. The determination of a twenty four hour urinary free cortisol
esulted normal and a high-dose dexamethasone suppression test
2 mg  every 6 h for eight doses) induced a partially suppression of
Fig. 2. Computed tomography: (a) presence of a solid mass in the bronphragm with ipsilateral scanty pleural effusion.
ACTH secretion. Moreover, the patient underwent a brain MRI  that
excluded the presence of a pituitary microadenoma.
A ﬂexible bronchoscopy performed two months later showed
a complete recanalization of bronchus intermedius, with a partial
unblocking of middle and lower bronchi (Fig. 4). Surgical resection
was considered as therapy of choice, but bilobectomy was not per-
formed because of elevated intraoperative risk associated to the
severe obesity and respiratory failure. The patient was adviced a
dietary treatment and a conservative initial bronchoscopic treat-
ment for tumor eradication.
Despite of prescription the patient was  not able to lose weight
(just 10 kg in one year), he still presents persistent psychiatric
disorders and severe obesity. Two  rigid bronchoscopies were per-
formed during the year to avoid the local growth of the tumor and
chus intermedius; (b) atelectasis of middle and lower right lobe.
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Fig. 3. Flexible bronchoscopy reveals a solid mass obliterating completely the
bronchus intermedius.
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Pulmonary carcinoid tumors with Cushing’s syndrome: an aggressive variantig. 4. Flexible broncoscopy performed after partial resection of the neoplasm. In
he ﬁgure are visible residual neoplastic tissue and the origins of the middle and
ower bronchi.
ontrol the possible differentiation of typical (TC) versus atypical
AC) histological type of pulmonary carcinoid. Anyway, the surgical
esection represents the subsequently appropriate step.
. Discussion
Carcinoids account for 1–2% of all pulmonary neoplasms in
dults and approximately 25–30% of all carcinoid tumors [4–19].
hey are considered to be a low grade malignancy belonging to the
pectrum of neuroendocrine tumors. In 2004, the WHO  devised
 new classiﬁcation for bronchopulmonary carcinoids based upon
 spectrum of clinicopathological entities ranging from hyper-
lastic neuroendocrine cell lesions (carcinoid tumorlets, diffuse
diopathic pulmonary neuroendocrine cell hyperplasia) to high
rade neuroendocrine tumors (small cell carcinoma and large cell
euroendocrine carcinoma). The initial presentation can be in the
arenchyma or mainly in the airways and are described as bronchial
arcinoids. Approximately 10–20% of pulmonary carcinoids are
typical carcinoids (AC), 80–90% are typical carcinoids (TC). Typical
arcinoids are well differentiated, can exhibit distinct recognized
istologic pattern (insular, trabecular, glandular, mixed or undiffer-
ntiated) and rare mitoses. They usually present as perhilar masses
nd are generally asymptomatic; however some patients mayPEN  ACCESS
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present recurrent pneumonia, cough, hemoptysis and chest pain.
Ectopic secretion of biologically active hormones is not uncom-
mon, in particular corticotrophin and growth hormone and it occurs
in fewer of 5% of patients with these tumors. Conversely, atyp-
ical carcinoids represent an intermediate grade neuroendocrine
tumors; they may  exhibit increased nuclear atypia, focal necro-
sis or high mitotic indices and their clinical course is aggressive
with an high incidence of mediastinal lymphnode metastases and
a 5-year survival rate of 40–75% [20]. Surgical resection is the pre-
ferred treatment of bronchopulmonary carcinoid tumors, anyway
the improvement of diagnostic and therapeutic techniques and fur-
ther understanding of tumor biology are driving new minimally
invasive approaches to diagnosis and therapy of these tumors.
Recent literature reports that the initial bronchoscopic treatment
seems to be a justiﬁable approach for bronchial carcinoids instead
of immediate surgical exploration and resection, because of an
excellent long term outcome [21]. These studies justiﬁed our treat-
ment approach in the reported case. Surgery could be associated
to an elevate intraoperative risk, the choice of treating with rigid
bronchoscopy can reduce the risk and improve the quality of life of
the patient, although it does not produce a radical resolution.
Cushing’s syndrome can be caused by an excess ACTH produc-
tion by a pituitary corticotroph adenoma, an extrapituitar tumor
(ectopic ACTH syndrome) or, very rarely, by a tumor secreting
CRH (ectopic CRH syndrome). Ectopic ACTH secretion occurs in
15–20% of patients with ACTH dependent Cushing’s syndrome with
the lung being the origin of over 45% of ACTH-producing tumors
(ectopic), followed by thymus (11%) and pancreas (8%). Cushing’s
syndrome is characterized by presence of central obesity, associ-
ated with systemic arterial hypertension, hyperlipidemia, impaired
glucose tolerance or diabetes and hypercoagulability [22]. An ele-
vated number of psychiatric and psycological disorders can be
associated with Cushing syndrome. A percentage between 50 and
80% of Cushing syndrome patients meet “Diagnostic and Statistical
Manual of Mental Disorders IV criteria of major depression”, while
a minority of them have other psychopathological manifestations
including mania, anxiety and cognitive disfunction. Has been also
reported suicidal tendency in patients with CS and the presence
of depressive symptoms can be an early manifestation of CS [23].
Psychological and psychiatric symptoms improve with the normal-
ization of cortisol levels in blood, obtained with surgical approach
[24–30].
In conclusion the evidence of central obesity, purple striae on
the abdomen, prominent eyes, round facies, skin hyperpigmenta-
tion and the concomitant and early appearance of psychological
disorder, in a patient affected by typical bronchial carcinoid, was
strongly suggestive of Cushing’s syndrome, but the diagnosis was
not conﬁrmed by laboratory ﬁndings, although it is not possible
completely to exclude the periodic secretion of ectopic cortisol
ACTH/CRH correlated.
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